Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Cash from Operations (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Cash from Operations for 16 consecutive years, with 27697000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 16.72% year-over-year to 27697000.0, compared with a TTM value of 33347000.0 through Dec 2025, up 29.3%, and an annual FY2025 reading of 33347000.0, up 29.3% over the prior year.
  • Cash from Operations was 27697000.0 for Q4 2025 at Orthofix Medical, up from 12402000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 27697000.0 in Q4 2025 and bottomed at 34020000.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 1016050.0, with a median of 1412500.0 recorded in 2022.
  • The sharpest move saw Cash from Operations crashed 415.81% in 2022, then skyrocketed 2346.75% in 2024.
  • Year by year, Cash from Operations stood at 11779000.0 in 2021, then plummeted by 80.07% to 2348000.0 in 2022, then tumbled by 385.09% to 6694000.0 in 2023, then surged by 454.5% to 23730000.0 in 2024, then increased by 16.72% to 27697000.0 in 2025.
  • Business Quant data shows Cash from Operations for OFIX at 27697000.0 in Q4 2025, 12402000.0 in Q3 2025, and 11639000.0 in Q2 2025.